jhonny peralta getty

Let’s pump the brakes on the “PED use got Jhonny Peralta his big deal” talk


With a respectful nod to Ken Rosenthal, our own Bill Baer and the players who have taken to Twitter in the past couple of days to talk about Jhonny Peralta, may I ask why everyone seems to think that Peralta’s new contract represents some sort of problem with the drug penalty system in baseball and the incentives that flow therefrom? Because from where I’m sitting, it’s way more complicated than that.

I get the superficial appeal of the argument that goes “Peralta got busted for PEDs and then he gets a four-year, $52 million deal. What’s up with that?!” But that argument totally ignores the nature of the current free agent market to begin with.

Here’s a shocking idea: Jhonny Peralta got a big crazy free agent contract, not because he used PEDs, thereby messing up the incentive system, but because everyone in free agency is getting a big crazy free agent contract these days.

Those shaking their heads at Peralta say things like “clearly the current drug penalties are not hurting players’ market value.” But if you swap in phrases like “being hurt,” “being average” or “severely underperforming expectations” for “the current drug penalties” it explains current reality too. Dan Haren is coming off two injury-plagued and often ineffective years and he got $10 million. Jason Vargas got four-years, $32 million as a back-of-the-rotation starter. Tim Hudson has been pretty bad and got two-years, $23 million. Carlos Ruiz got three-years, $26 million. Why isn’t anyone talking about how their deals are confounding the incentive system that’s supposed to be in place?

Probably because they’re not. They’re getting what the market — currently flush with billions of dollars in new broadcast dollars and vanishingly small ways for teams to spend money on amateur and international signings — allows. Look around at the crop of shortstop talent in Major League Baseball at the moment and tell me that talent isn’t hard to come by. Then tell me that Peralta’s deal has more to do with him being a PED user than him simply being a good shortstop in a weak shortstop market who happened to hit free agency at the right time.

The fact that a team — a smart team, by the way — is spending serious money on Jhonny Peralta right now is because he’s in the market. Increase the ban to 100 games? Sure, maybe that would work for a guy whose ban coincided with his free agency, but it doesn’t always, or even often, work that way. Say a guy gets a ban in the second year of his three year deal, comes back in year three and plays well prior to becoming a free agent. Say a player tests positive in the spring of his walk year, serves his 100 games and then comes back in late July and lights it up just before free agency. You think those guys are not going to get paid the following offseason? Of course they are. Because they’ll be active players with marketable skills and teams like to give those guys lots of money.

The only way totally eliminate the idea of guys who take PEDs from later getting paid is to give permanent bans for first offenses. But of course that’s crazy. It’d be an ultra-extreme response to a problem that no one has demonstrated calls for such a solution and which would likely end the careers of some players based on false positives or inadvertent ingestion of PEDs. And no one who grouses about Jhonny Peralta allegedly screwing with the incentive system would ever seriously make that argument, would they? I seriously doubt it.

Peralta got paid because he’s a good player at a position with scant available talent in a market that is paying through the nose for even ordinary talent. If that’s troublesome to you, you have a lot of things to worry about besides whether 50-game suspensions are sufficient to deter PED use.

Mariners interested in free agent outfielder Nori Aoki

AP Photo/Ben Margot
Leave a comment

New Mariners general manager Jerry Dipoto has kept pretty busy in his short time on the job and Bob Dutton of the Tacoma News Tribune reports that free agent outfielder Nori Aoki could be his next target. The club recently pursued a trade for Marlins outfielder Marcell Ozuna, but the asking price has them looking at alternatives.

Aoki, who turns 34 in January, has hit .287 with a .353 on-base percentage over four seasons since coming over from Japan. He was having a fine season with the Giants this year prior to being shut down in September with lingering concussion symptoms.

The Giants decided against picking up Aoki’s $5.5 million club option for 2016 earlier this month, but he should still do pretty well for himself this winter assuming he’s feeling good.

Report: Johnny Cueto is believed to be looking for a $140-160 million deal

AP Photo/Matt Slocum
Leave a comment

It was reported Sunday that free agent right-hander Johnny Cueto had turned down a six-year, $120 million contract from the Diamondbacks. He’s hoping to land a bigger deal this winter and ESPN’s Jerry Crasnick has heard some chatter about what he’s looking for.

Jordan Zimmermann finalized a five-year, $110 million contract with the Tigers today, which works out to $22 million per season. Arizona’s offer to Cueto checked in at $20 million per season. A six-year offer to Cueto at the same AAV (average annual value) as Zimmermann would put him at $132 million, which is still a little shy of the figure stated by Crasnick. Of course, Cueto owns a 2.71 ERA (145 ERA+) over the last five seasons compared to a 3.14 ERA (123 ERA+) by Zimmermann during that same timespan, so there’s a case to be made that he should get more. Still, he’s the clear No. 3 starter on the market behind David Price and Zack Greinke.

CBS Sports’ Jon Heyman reports that the Dodgers, Giants, Red Sox, and Cubs are among the other teams who have interest in Cueto. One variable in his favor is that he is not attached to draft pick compensation, as he was traded from the Reds to the Royals during the 2015 season.

Report: Around 20 teams have contacted the Braves about Shelby Miller

AP Photo/John Bazemore
Leave a comment

The rebuilding Braves have already been active on the trade market and they might not be done, as CBS Sports’ Jon Heyman reports that right-hander Shelby Miller has been a very popular name. In fact, around 20 teams have checked in.

Nothing is considered close and the Braves have set a very high asking price, mostly centered around offense. They asked for right-hander Luis Severino in talks with the Yankees and would expect outfielder Marcell Ozuna among other pieces from the Marlins. The Diamondbacks and Giants are among the other interested clubs.

Miller is under team control through 2018, so there’s not necessarily a sense of urgency to move him, but anything is possible with the way the Braves are doing things right now. The 25-year-old is coming off a year where he went 6-17, but that was about really rotten luck more than anything else, as he had a fine 3.02 ERA and 171/73 K/BB ratio over 205 1/3 innings. The Braves gave him the worst run support of any starter in the majors.

Mets expected to tender a contract to Jenrry Mejia

NEW YORK, NY - JULY 12:  Jenrry Mejia #58 of the New York Mets reacts as he walks off the field after getting the final out of the seventh inning against the Arizona Diamondbacks at Citi Field on July 12, 2015 in the Flushing neighborhood of the Queens borough of New York City.  (Photo by Jim McIsaac/Getty Images)
Photo by Jim McIsaac/Getty Images

Jenrry Mejia appeared in just seven games this past season due to a pair of suspensions for performance-enhancing drugs, but Adam Rubin of ESPN New York reports that the Mets are expected to tender him a contract for 2016.

While the Mets were vocal about their disappointment in Mejia’s actions, it makes sense to keep him around as an option. Had he played a full season in 2015, he would have earned $2.595 million. He’s arbitration-eligible for the second time this winter and figures to receive a contract similar to his 2015 figure, but he’ll only be paid for the games he plays. He still has 100 games to serve on his second PED suspension, which means that he’ll only be paid for 62 games in 2016. This likely puts his salary closer to $1 million, which is a small price to pay for someone who could prove useful during the second half and beyond. He also won’t count toward the team’s 40-man roster until he’s active.

Mejia, who turned 26 in October, owns a 3.68 ERA in the majors and saved 28 games for the Mets in 2014. He’s currently pitching as a starter in the Dominican Winter League.